News JW Pharmaceutical Corporation

Equities

A001060

KR7001060003

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-04-25 pm EDT			5-day change	1st Jan Change
30,400 ^KRW	+2.01%		+4.29%	-14.49%

Mar. 14	JW Pharmaceutical Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Jan. 22	CJ Logistics Secures Distribution Deal for JW Pharm's Intravenous Solutions	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

JW Pharmaceutical Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 14	CI
CJ Logistics Secures Distribution Deal for JW Pharm's Intravenous Solutions	Jan. 22	MT
JW Pharmaceutical Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 13	CI
South Korean Shares Touch Seven-Month Low on Concerns over US Fed Rate Hikes	23-10-20	MT
JW Pharmaceutical Faces Potential Fine of Nearly 30 Billion Won for Alleged Illegal Rebates	23-10-20	MT
JW Pharmaceutical Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14	CI
JW Pharmaceutical Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15	CI
Celleron Therapeutics Ltd acquired Argonaut Therapeutics Limited from JW Pharmaceutical Corporation and Oxford Science Enterprises.	23-01-04	CI
JW Pharmaceutical Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-14	CI
JW Pharmaceutical to Raise $3 Million via Share Sale	22-10-20	MT
JW Pharmaceutical Corporation announced that it expects to receive KRW 9.999993492 billion in funding	22-10-19	CI
JW Pharmaceutical Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-16	CI
JW Pharmaceutical Corporation Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-16	CI
JW Pharmaceutical Corporation Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-21	CI
JW Pharmaceutical Corporation announced that it has received KRW 398.470716 million in funding	21-12-12	CI
JW Pharmaceutical Corporation announced that it expects to receive KRW 398.470716 million in funding	21-12-02	CI
JW Pharmaceutical Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-15	CI
JW Pharmaceutical Corporation(KOSE:A001060) dropped from KOSPI 200 Index	21-09-14	CI
JW Pharmaceutical Corporation announced that it has received KRW 300 million in funding	21-06-17	CI
Market Chatter: JW Pharmaceutical Gets German Health Body's Permit for Phase 2a Study of Oral Atopic Dermatitis Drug	21-04-21	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News JW Pharmaceutical Corporation

Equities

A001060

KR7001060003

Summary

Filters